Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrasimod in moderate to severe active ulcerative colitis (Phase III)
CTR20192294Phase 3Completed
- Sponsor
- Yunyi Pharmaceutical
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etrasimod in autoimmune colitis, sponsored by Yunyi Pharmaceutical. Started Dec 2019; status: completed.
02
Drugs
etrasimod
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20192294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192294.